SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-140713
Filing Date
2023-05-10
Accepted
2023-05-10 16:08:57
Documents
9
Period of Report
2023-05-10

Document Format Files

Seq Description Document Type Size
1 6-K d346858d6k.htm 6-K 9760
2 EX-99.1 d346858dex991.htm EX-99.1 175277
3 EX-99.2 d346858dex992.htm EX-99.2 6058
4 GRAPHIC g346858dsp005a.jpg GRAPHIC 5701
5 GRAPHIC g346858dsp005b.jpg GRAPHIC 3955
6 GRAPHIC g346858dsp020.jpg GRAPHIC 8488
7 GRAPHIC g346858dsp4.jpg GRAPHIC 3529
8 GRAPHIC g346858dsp4a.jpg GRAPHIC 6581
9 GRAPHIC g346858g0510183958159.jpg GRAPHIC 6218
  Complete submission text file 0001193125-23-140713.txt   240419
Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 41 61 551 30 30
VectivBio Holding AG (Filer) CIK: 0001836379 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40316 | Film No.: 23906415
SIC: 2836 Biological Products, (No Diagnostic Substances)